Research study Program year 2024 Source: CMS Open Payments

A Multicenter Low Interventional Study to Develop A Prospective Clinicogenomic Program

Research payments

$1,720,371

370 payments

Through program year 2024, $1,720,371 in research payments was reported against A Multicenter Low Interventional Study to Develop A Prospective Clinicogenomic Program, across 370 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$2,650	3
2023	Research	$21,591	21
2022	Research	$54,427	43
2021	Research	$949,375	221
2020	Research	$692,328	82

Breakdown

Who paid Research payments · program years 2020–2024

Genentech, Inc. $1,720,371 370 payments

Who received the money Research payments · program years 2020–2024

Sarah Cannon Research Institute LLC Institute LLC Organisation paid for research $351,091 107 payments
Birmingham Hematology + Oncology Assoc LLC Organisation paid for research $217,830 26 payments
Virginia Cancer Institute Reynolds Crossing Organisation paid for research $211,344 21 payments
National Translational Research Organisation paid for research $161,754 9 payments
Regional Cancer Care Associates Organisation paid for research $109,993 16 payments
Cancer + Hematology Centers Of Western Michigan Organisation paid for research $101,315 13 payments
Southeast Nebraska Hematology And Oncology Consultants Pc Dba Southeast Nebraska Cancer Center Organisation paid for research $84,141 13 payments
Hematology Oncology Associates Of Central New York Organisation paid for research $83,597 20 payments
Piedmont Cancer Institute Organisation paid for research $77,076 7 payments
Hematology Oncology Associates Of Fredericksburg Organisation paid for research $43,235 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.